JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Neff, N.
Right arrow Articles by Rabinowitz, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Neff, N.
Right arrow Articles by Rabinowitz, J. L.
Journal of Pharmacology And Experimental Therapeutics, Vol. 144, Issue 1, 1-7, 1964
Copyright © 1964 by American Society for Pharmacology and Experimental Therapeutics


DISTRIBUTION AND METABOLISM OF MESCALINE-C IN THE CAT BRAIN

N. Neff 1, G. V. Rossi 1, G. D. Chase 1, and J. L. Rabinowitz 1

1 Department of Pharmacology and Department of Radiochemistry, Philadelphia College of Pharmacy and Science, Philadelphia, Pennsylvania

Autoradiograms of serial sectiomis and extractions of selected neuroanatomical areas of the brain removed from cats at various times after the intravenous injection of mescaline-agr-C14 HCl indicated a relatively high concentration of radioactivity in cortical amid subcortical gray matter. In contrast, areas composed largely of myelinated fibers evidenced relatively little activity. Removal of mescaline from the blood, plasma and CSF followed a first order rate; the biological half-life of mescaline in plasma and CSF was 90 to 120 minutes. Maximum concentration of mescaline in the brain was attained between frac12 and 2 hours, which corresponded approximateIy to the period of maximal intoxication as evaluated by gross observation.

Only two radioactive components, identified as mescaline and 3,4,5-trimethoxyphenylacetic acid (TMPA), were found in cat brain, plasma, CSF and urine after the administration of C14- labeled mescaline. Chromatographic analysis did not reveal the presence, in these samples, of any of a number of other postulated metabolites of mescaline. Indirect evidence suggests that mescaline may be biotransformed to TMPA in cat brain.

Submitted on August 26, 1963
Accepted on November 27, 1963







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1964 by the American Society for Pharmacology and Experimental Therapeutics.